Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review

von Calverley, Peter, Rogliani, Paola, Papi, Alberto
Veröffentlicht in Drug Saf (2020)

Rate of Decline of FEV(1) as a Biomarker of Survival?

von Papi, Alberto, Beghé, Bianca, Fabbri, Leonardo M.
Veröffentlicht in Am J Respir Crit Care Med (2021)

Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond

von Saturni, Sara, Contoli, Marco, Spanevello, Antonio, Papi, Alberto
Veröffentlicht in Allergy Asthma Immunol Res (2015)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study

von Singh, Dave, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Veröffentlicht in Int J Chron Obstruct Pulmon Dis (2017)

Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study

von Papi, Alberto, Di Stefano, Andrea F. D., Radicioni, Milko
Veröffentlicht in Adv Ther (2020)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

von Scichilone, Nicola, Benfante, Alida, Morandi, Luca, Bellini, Federico, Papi, Alberto
Veröffentlicht in Patient Relat Outcome Meas (2014)

Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

von Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Veröffentlicht in NPJ Prim Care Respir Med (2016)

Mechanisms of rhinovirus-induced asthma

von Papadopoulos, Nikolaos G, Papi, Alberto, Psarras, Stelios, Johnston, Sebastian L
Veröffentlicht in Paediatr Respir Rev (2004)

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations

von Nicolini, Gabriele, Scichilone, Nicola, Bizzi, Andrea, Papi, Alberto, Fabbri, Leonardo M
Veröffentlicht 2008

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

von Vanfleteren, Lowie, Fabbri, Leonardo M, Papi, Alberto, Petruzzelli, Stefano, Celli, Bartolome
Veröffentlicht in Int J Chron Obstruct Pulmon Dis (2018)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

von Singh, Dave, Fabbri, Leonardo M, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Veröffentlicht in Int J Chron Obstruct Pulmon Dis (2019)

Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease

von Pascoe, Steven J., Papi, Alberto, Midwinter, Dawn, Lettis, Sally, Barnes, Neil
Veröffentlicht in Respir Res (2019)

Models of infection and exacerbations in COPD

von Papi, Alberto, Contoli, Marco, Gaetano, Caramori, Mallia, Patrick, Johnston, Sebastian L
Veröffentlicht in Curr Opin Pharmacol (2007)

Management of chronic refractory cough in adults

von Visca, Dina, Beghè, Bianca, Fabbri, Leonardo Michele, Papi, Alberto, Spanevello, Antonio
Veröffentlicht in Eur J Intern Med (2020)

New drugs targeting Th2 lymphocytes in asthma

von Caramori, Gaetano, Groneberg, David, Ito, Kazuhiro, Casolari, Paolo, Adcock, Ian M, Papi, Alberto
Veröffentlicht 2008

A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with...

von Virchow, J. Christian, Rodriguez-Roisin, Roberto, Papi, Alberto, Shah, Tushar P., Gopalan, Gokul
Veröffentlicht in BMC Pulm Med (2016)

Treatment strategies for asthma: reshaping the concept of asthma management

von Papi, Alberto, Blasi, Francesco, Canonica, Giorgio Walter, Morandi, Luca, Richeldi, Luca, Rossi, Andrea
Veröffentlicht in Allergy Asthma Clin Immunol (2020)

ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy

von Cruz, Álvaro A., Barile, Sara, Nudo, Elena, Brogelli, Laura, Guller, Patricia, Papi, Alberto
Veröffentlicht in Asthma Res Pract (2021)

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial

von Papi, Alberto, Nicolini, Gabriele, Crimi, Nunzio, Fabbri, Leonardo, Olivieri, Dario, Rossi, Andrea, Paggiaro, Pierluigi
Veröffentlicht 2012

The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD

von Papi, Alberto, Jones, Paul W, Dalvi, Prashant S, McAulay, Kirsten, McIver, Tammy, Dissanayake, Sanjeeva
Veröffentlicht in Int J Chron Obstruct Pulmon Dis (2015)